rolipram has been researched along with Glomerulonephritis, Membranoproliferative in 1 studies
Glomerulonephritis, Membranoproliferative: Chronic glomerulonephritis characterized histologically by proliferation of MESANGIAL CELLS, increase in the MESANGIAL EXTRACELLULAR MATRIX, and a thickening of the glomerular capillary walls. This may appear as a primary disorder or secondary to other diseases including infections and autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Various subtypes are classified by their abnormal ultrastructures and immune deposits. Hypocomplementemia is a characteristic feature of all types of MPGN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuboi, Y | 1 |
| Shankland, SJ | 1 |
| Grande, JP | 1 |
| Walker, HJ | 1 |
| Johnson, RJ | 1 |
| Dousa, TP | 1 |
1 other study available for rolipram and Glomerulonephritis, Membranoproliferative
| Article | Year |
|---|---|
Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Actins; Animals; Blood Pressure; Calcium-Calmodulin-Dependent P | 1996 |